CNSP
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
PTGX
Price
$43.17
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
125 days until earnings call
Ad is loading...

CNSP vs PTGX

Header iconCNSP vs PTGX Comparison
Open Charts CNSP vs PTGXBanner chart's image
CNS Pharmaceuticals
Price$0.13
Change-$0.00 (-0.00%)
Volume$12.79M
CapitalizationN/A
Protagonist Therapeutics
Price$43.17
Change-$0.00 (-0.00%)
Volume$652.87K
CapitalizationN/A
CNSP vs PTGX Comparison Chart
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CNSP vs. PTGX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a StrongSell and PTGX is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CNSP: $0.13 vs. PTGX: $43.19)
Brand notoriety: CNSP and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 69% vs. PTGX: 105%
Market capitalization -- CNSP: $4.99M vs. PTGX: $2.54B
CNSP [@Biotechnology] is valued at $4.99M. PTGX’s [@Biotechnology] market capitalization is $2.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 0 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • CNSP’s FA Score: 0 green, 5 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, PTGX is a better buy in the long-term than CNSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 3 TA indicator(s) are bullish while PTGX’s TA Score has 3 bullish TA indicator(s).

  • CNSP’s TA Score: 3 bullish, 5 bearish.
  • PTGX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than PTGX.

Price Growth

CNSP (@Biotechnology) experienced а +15.07% price change this week, while PTGX (@Biotechnology) price change was -5.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

CNSP is expected to report earnings on Mar 16, 2023.

PTGX is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($2.54B) has a higher market cap than CNSP($4.99M). PTGX YTD gains are higher at: 88.356 vs. CNSP (-99.799). PTGX has higher annual earnings (EBITDA): 156M vs. CNSP (-15.95M). PTGX has more cash in the bank: 564M vs. CNSP (1.49M). CNSP has less debt than PTGX: CNSP (123K) vs PTGX (11M). PTGX has higher revenues than CNSP: PTGX (319M) vs CNSP (0).
CNSPPTGXCNSP / PTGX
Capitalization4.99M2.54B0%
EBITDA-15.95M156M-10%
Gain YTD-99.79988.356-113%
P/E RatioN/A15.57-
Revenue0319M-
Total Cash1.49M564M0%
Total Debt123K11M1%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNSPPTGX
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 14 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXDO5.350.08
+1.52%
Crexendo
PAYC228.891.19
+0.52%
Paycom Software
SANA2.85-0.05
-1.56%
Sana Biotechnology
RHE1.64-0.03
-1.87%
Regional Health Properties
PTVE11.54-0.46
-3.83%
Pactiv Evergreen

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with VIR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
-0.23%
VIR - CNSP
36%
Loosely correlated
-6.28%
AAVXF - CNSP
34%
Loosely correlated
N/A
PTGX - CNSP
30%
Poorly correlated
-7.12%
HOWL - CNSP
26%
Poorly correlated
-2.73%
NRIX - CNSP
26%
Poorly correlated
-3.98%
More

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with RCUS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
-7.12%
RCUS - PTGX
41%
Loosely correlated
-5.52%
ARDX - PTGX
41%
Loosely correlated
-6.23%
VRDN - PTGX
41%
Loosely correlated
-12.72%
VIR - PTGX
41%
Loosely correlated
-6.28%
CRNX - PTGX
40%
Loosely correlated
-2.05%
More